InnoPharmax Inc. (4172.TWO)

TWD 17.1

(-0.87%)

Long Term Debt Summary of InnoPharmax Inc.

  • InnoPharmax Inc.'s latest annual long term debt in 2023 was 5.38 Million TWD , down -45.39% from previous year.
  • InnoPharmax Inc.'s latest quarterly long term debt in 2024 Q2 was 3.11 Million TWD , down 0.0% from previous quarter.
  • InnoPharmax Inc. reported annual long term debt of 9.86 Million TWD in 2022, up 814.09% from previous year.
  • InnoPharmax Inc. reported annual long term debt of 1.07 Million TWD in 2021, down -80.33% from previous year.
  • InnoPharmax Inc. reported quarterly long term debt of 3.11 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • InnoPharmax Inc. reported quarterly long term debt of 5.38 Million TWD for 2023 FY, down -45.39% from previous quarter.

Annual Long Term Debt Chart of InnoPharmax Inc. (2023 - 2019)

Historical Annual Long Term Debt of InnoPharmax Inc. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 5.38 Million TWD -45.39%
2022 9.86 Million TWD 814.09%
2021 1.07 Million TWD -80.33%
2020 5.48 Million TWD -41.61%
2019 9.39 Million TWD 0.0%

Peer Long Term Debt Comparison of InnoPharmax Inc.

Name Long Term Debt Long Term Debt Difference
Allied Biotech Corporation 72.02 Million TWD 92.522%
GeneFerm Biotechnology Co., Ltd. 76.14 Million TWD 92.927%
Easywell Biomedicals, Inc. 330.44 Million TWD 98.37%
TTY Biopharm Company Limited 403.04 Million TWD 98.664%
Synmosa Biopharma Corporation 1.45 Billion TWD 99.631%
Orient EuroPharma Co., Ltd. 2.2 Billion TWD 99.756%
Center Laboratories, Inc. 4.42 Billion TWD 99.878%
Tien Liang BioTech Co., Ltd. 377 Thousand TWD -1328.647%
Orient Pharma Co., Ltd. 323.73 Million TWD 98.336%
Johnson Chemical Pharmaceutical Works Co., Ltd. 100.83 Million TWD 94.658%
Excelsior Biopharma Inc. 300.25 Million TWD 98.206%
DV Biomed Co., Ltd. 315.74 Million TWD 98.294%
Foresee Pharmaceuticals Co., Ltd. 13.11 Million TWD 58.933%
Handa Pharmaceuticals, Inc. 7.67 Million TWD 29.788%
UniPharma Co., Ltd. - TWD -Infinity%
Anxo Pharmaceutical Co., Ltd. 499.69 Million TWD 98.922%
Alar Pharmaceuticals Inc. 138 Thousand TWD -3802.899%
Winston Medical Supply Co., Ltd. 56.05 Million TWD 90.392%
Mercury Biopharmaceutical Corporation 41.66 Million TWD 87.074%
Bioray Biotech Co., Ltd 65.65 Million TWD 91.797%
TSH Biopharm Corporation Limited - TWD -Infinity%